The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis
Open Access
- 30 July 2005
- journal article
- clinical trial
- Published by Springer Nature in Diabetologia
- Vol. 48 (9) , 1749-1755
- https://doi.org/10.1007/s00125-005-1858-4
Abstract
Emerging data suggest that different indices of glycaemia are risk factors for clinical events. The aim of this analysis was to investigate the relationship between fasting plasma glucose or glycated haemoglobin (GHb) levels and incident cardiovascular (CV) outcomes, death, heart failure and overt nephropathy in diabetic and non-diabetic individuals enrolled in the Heart Outcomes Prevention Evaluation (HOPE) study.Keywords
This publication has 28 references indexed in Scilit:
- Is the Current Definition for Diabetes Relevant to Mortality Risk From All Causes and Cardiovascular and Noncardiovascular Diseases?Diabetes Care, 2003
- Development of Renal Disease in People at High Cardiovascular RiskJournal of the American Society of Nephrology, 2003
- Dysglycemia: A Key Cardiovascular Risk FactorSeminars in Vascular Medicine, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.Diabetes Care, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Glucose tolerance and mortality, including a substudy of tolbutamide treatmentDiabetologia, 1997
- Rationale and Design of a Large Study to Evaluate the Renal and Cardiovascular Effects of an ACE Inhibitor and Vitamin E in High-Risk Patients With Diabetes: The MICRO-HOPE StudyDiabetes Care, 1996
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995